We're not putting too much stock into any of these casting claims, but following this past week's Professor X and Jean Grey rumours, there's a possible update on the MCU's Magneto. According to ...

In other words, it could be mistaken for a software patch. After all, the new logo has not been updated on Android and other platforms, or at least not yet. No big reveal this time. No corporate ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex’s research guru has warned that it could take another 15 years to produce a suite of medicines that treat all strains of the disease, saying that a deal with the NHS will be crucial to ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Vertex Pharmaceuticals' shares dropped due to poor first-quarter results. Vertex's business and prospects remain attractive. Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Vertex Associates Private Limited is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 1.0 lakhs and ...

Vertex Securities Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 35.67 Crore) operating in Financial Services sector. Vertex Securities Ltd. key ...